June 27, 2021 Comments Off on New patent expiration for Novartis drug UTIBRON Posted in: Uncategorized
Annual Drug Patent Expirations for UTIBRON Utibron is a drug marketed by Novartis and is included in one NDA. There are thirteen patents protecting this drug. Drug patent litigation for…
The post New patent expiration for Novartis drug UTIBRON appeared…
June 27, 2021 Comments Off on Drug Patent Expirations for the Week of June 27, 2021 Posted in: Uncategorized
UTIBRON (glycopyrrolate; indacaterol maleate) Novartis Patent: 8,956,661 Expiration: Jun 27, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
T…
